Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 9.6% ($ weighted) with an average mark-down of 2% (equal weighted). The period saw one advancing company for every declining company.
  • Sentiment up:
  • Sentiment down:
  • In November, 28% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 41% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: September 30th, 2025 Reporting Period

9.6%

Appreciation/Depreciation of All Reported Holdings1

-2.0%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Claris Bio
356.8%
Galvanize
125.0%
Wugen
96.3%
Crusoe Energy
89.4%
Oura Health
68.7%
OpenAI
62.1%
Anthropic
61.5%
Vanta
56.8%
Jerry
54.2%
Noodle
51.0%
Lambda Labs
46.1%
Databricks
45.1%
JUUL
38.1%
Ramp
36.9%
Groq
32.0%
Valo Health
30.9%
Blink Health
30.8%
Celonis
30.6%
Epirus
30.5%
PayJoy
30.5%
KoBold Metals
28.1%
Einride
26.3%
Runway AI
24.2%
Whoop
22.2%
Canva
22.1%
Bytedance
20.2%
Anchorage
19.1%
Teya (SaltPay)
19.0%
Rivos
17.4%
Andpad
16.2%
Leapwork
16.1%
Somatus
16.1%
goPuff
15.8%
Ursa
15.7%
Revolut
15.6%
Lightmatter
15.0%
SpaceX
14.6%
Meesho
13.7%
Celestial AI
12.4%
Diamond Foundry
12.4%
Strive Health
11.9%
Moloco
11.5%
HawkEye 360
11.0%
Jumo
10.5%
RapidSOS
10.5%
Evozyne
10.1%
Fundbox
10.0%
Aiven
9.8%
Retym
9.7%
Ant Group
8.8%
StormWind
8.7%
SmartHR
8.1%
Locus Robotics
7.5%
Bolt
7.2%
GroundTruth
6.9%
Deepgram
6.3%
ElevateBio
6.1%
Apartment List
5.9%
Loadsmart
5.8%
YAP Therapeutics
5.5%
Zipline
5.5%
Tealium
5.4%
Docker
5.3%
Included Health (Grand Rounds)
5.3%
Lyra Health
5.2%
Musely
5.1%
Prosper Marketplace
5.1%
Tory Burch
5.0%
MasterClass
4.9%
SiMa ai
4.7%
Discord
4.6%
Upgrade
4.5%
Lime
4.0%
Newfront Insurance
4.0%
Cohere Technologies
3.8%
Asimov
3.7%
OpenX
3.3%
Skyryse
3.3%
Plaid
3.1%
Akeana
3.0%
Kardium
3.0%
Sierra Space
3.0%
Breeze Airways
2.9%
Cross River
2.7%
GrubMarket
2.4%
Ocrolus
1.9%
Tenstorrent
1.8%
EquipmentShare
1.6%
Aledade
1.5%
Anduril
1.2%
Roofstock
1.1%
Click Therapeutics
1.0%
Tarana
0.9%
Bombas
0.8%
Medical Micro
0.8%
Stripe
0.8%
PsiQuantum
0.7%
Rapyd
0.7%
ThoughtSpot
0.7%
StockX
0.6%
Tanium
0.4%
AnyRoad
0.3%
Automation Anywhere
0.3%
Fanatics
0.3%
ABL Space
0.2%
Arctic Wolf
0.2%
Empower Semi
0.2%
FLEXE
0.2%
Nuro
0.2%
xAI
0.2%
Cleerly
0.1%
Gusto
0.1%
Motive (KeepTruckin)
0.1%
Waymo
0.1%
ADARx
0.0%
Airtable
0.0%
Aktis Oncology
0.0%
Anyscale
0.0%
Arbor Bio
0.0%
Arcadia
0.0%
ArsenalBio
0.0%
AtoB
0.0%
Avalyn Pharma
0.0%
Axiom Space
0.0%
Bolt Financial
0.0%
Capsule
0.0%
Cellanome
0.0%
Centrexion
0.0%
Checkr
0.0%
ChromaCode
0.0%
CiBo
0.0%
ClassDojo
0.0%
Clear Labs
0.0%
ClearMotion
0.0%
Cohesity
0.0%
Collective Health
0.0%
Color Genomics
0.0%
Cresta AI
0.0%
Curology
0.0%
Cybereason
0.0%
DBT Labs
0.0%
Deep Instinct
0.0%
Delfi
0.0%
Dialpad
0.0%
DittoLive
0.0%
Domino Data
0.0%
Earnin
0.0%
Eikon
0.0%
Element Labs
0.0%
EndeavorBio
0.0%
Envoy
0.0%
Eruditus
0.0%
EverDrop
0.0%
FabFitFun
0.0%
Filevine
0.0%
FlashParking
0.0%
FogPharma (Parabilis)
0.0%
Form Energy
0.0%
Forum Brands
0.0%
Freenome
0.0%
Generate Bio
0.0%
Genesis Therapeutics
0.0%
HaulHub
0.0%
Hightouch
0.0%
Honor Tech
0.0%
Hover
0.0%
Hydrow
0.0%
Icertis
0.0%
Immuta
0.0%
Impulse Dynamics
0.0%
InSilico
0.0%
Insitro
0.0%
Invaio Sciences
0.0%
I-Pulse
0.0%
Jeeves
0.0%
JOKR
0.0%
Kandou
0.0%
Kartos Therapeutics
0.0%
Laronde
0.0%
Lumicks
0.0%
Misfits Market
0.0%
Moveworks
0.0%
Nanotronics
0.0%
Neuralink
0.0%
Obsidian Therapeutics
0.0%
Odyssey Therapeutics
0.0%
Omio
0.0%
Orchard
0.0%
Overtime
0.0%
Pair Eyewear
0.0%
Passport
0.0%
Perplexity AI
0.0%
Public
0.0%
Rappi
0.0%
Resilience
0.0%
Rhino Labs
0.0%
Ring Therapeutics
0.0%
Ripple
0.0%
SandboxAQ
0.0%
Savage X
0.0%
Scribe
0.0%
Seaport Therapeutics
0.0%
SecurityScorecard
0.0%
Socure
0.0%
Stash
0.0%
Super73
0.0%
Tessera
0.0%
Third Arc Bio
0.0%
True Footage
0.0%
Turo
0.0%
Uniphore
0.0%
Verily
0.0%
WiTricity
0.0%
Betterment
-0.1%
Crossover Health
-0.1%
Zapp
-0.1%
Course Hero
-0.2%
Applied Intuition
-0.3%
DNA Script
-0.3%
INRIX
-0.3%
Evolve Vacation
-0.4%
Epic Games
-0.6%
Flexport
-0.6%
Liquid Death
-0.6%
Attentive
-0.7%
Brain Corp
-0.7%
GOAT
-0.9%
Cerebras
-1.1%
ContentSquare
-1.1%
Pine Labs
-1.1%
N26
-1.3%
DataRobot
-1.5%
Verbit
-1.6%
Dragos
-1.8%
Zocdoc
-1.8%
VAST Data
-1.9%
Asapp
-2.1%
Neon
-2.4%
Starling Bank
-2.4%
Kraken
-2.6%
JumpCloud
-3.3%
QuintoAndar
-3.5%
WorkRise
-3.5%
GupShup
-3.6%
SiFive
-3.6%
Skydio
-3.7%
Unqork
-3.8%
NextRoll
-4.0%
RealSelf
-4.0%
Minted
-4.4%
Tipalti
-4.5%
Caidya (dMed)
-5.0%
Tebra (PatientPop)
-5.1%
Acrisure
-5.3%
Automattic
-5.9%
Patreon
-6.0%
Contentful
-6.1%
Sila Nano
-6.5%
Impossible Foods
-7.1%
Kalderos
-7.1%
Devoted
-7.5%
Druva
-7.8%
Dapper Labs
-8.3%
Alamar Bio
-8.6%
Snyk
-9.2%
Trax
-9.2%
Contrast Security
-9.5%
Varo Money
-9.5%
Enevate
-9.7%
Foursquare
-9.9%
ConsenSys
-10.0%
IntelyCare
-10.3%
SirionLabs
-10.7%
Astranis
-11.0%
BigID
-11.0%
Abnormal AI
-11.2%
Dataminr
-11.5%
Insight M
-11.5%
Verge Genomics
-11.8%
Grammarly
-12.0%
FourKites
-12.1%
Shield AI
-12.5%
Farmers Business Network
-13.6%
Trumid
-14.0%
Lookout
-14.2%
Fabletics
-14.7%
Solugen
-15.4%
Treeline Bio
-15.4%
Bright Machines
-16.6%
Coalition
-16.8%
OfferUp
-17.4%
SingleStore
-17.4%
Validere
-17.4%
OpenSpace
-18.0%
Yotpo
-18.7%
Outreach
-19.8%
Algolia
-20.0%
Magic Leap
-20.0%
Redwood Materials
-20.6%
ResearchGate
-21.3%
Hearth
-21.5%
Xsight Labs
-23.2%
Element Bio
-26.8%
Snorkel AI
-27.3%
SkySafe
-28.2%
Thriveworks
-28.4%
BlueJay Therapeutics
-35.0%
SambaNova
-49.0%
Saluda Medical
-50.6%
Clarify Health
-51.2%
Carbon 3D
-57.7%
Voltron Data
-60.9%
CelLink
-62.3%
Rad Power
-65.6%
RefleXion Medical
-72.9%
PrognomIQ
-75.3%
Pivot Bio
-76.3%
Lessen
-83.1%
Nutcracker
-86.7%
Versa Networks
-88.5%
Caresyntax
-91.0%
Motif FoodWorks
-95.0%
FLYR
-100.0%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 9.6% ($ weighted) with an average mark-down of 2% (equal weighted). The period saw one advancing company for every declining company.

Claris Bio experienced the most significant mark-up, followed by Galvanize, Wugen and Crusoe Energy. AI & Machine Learning, SaaS, and Aerospace & Defense saw the largest mark-ups across sectors.

FLYR experienced the most significant mark-down as funds wrote off their positions. Motif FoodWorks, Caresyntax and Versa Networks also experienced significant mark-downs. Among sectors, AgTech, Data & Analytics and Media & Entertainment saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Click Therapeutics2+167.00%
GOAT1+161.70%
Anduril7+109.10%
Skydio1+107.70%
Algolia2+99.00%
VAST Data4+81.50%
Thirty Madison1+63.10%
Blink Health1+61.50%
Immuta2+56.80%
Checkr2+52.50%
Lambda Labs7+48.70%
Crusoe Energy7+43.70%
Anthropic7+43.00%
Applied Intuition6+39.80%
Cohesity2+38.10%
Shield AI7+37.90%
Freenome1+36.20%
xAI8+34.70%
Perplexity AI7+28.90%
Databricks7+28.50%
Stripe8+28.40%
Grammarly2+27.40%
Color Genomics1+21.10%
Neuralink4+19.40%
Revolut4+16.40%
BigID2+15.20%
SpaceX7+11.60%
Canva3+10.90%
SambaNova1+9.50%
Moloco1+9.30%
Celonis2+8.10%
Astranis2+6.70%
Cerebras6+6.70%
Whoop5+6.20%
Tenstorrent1+4.50%
Groq5+4.50%
Redwood Materials6+4.20%
Intercom6+2.20%
Airtable3+1.80%
Replit6+0.80%
Gusto2+0.00%
iCapital5-0.50%
SandboxAQ2-0.60%
PsiQuantum6-1.60%
Bolt1-1.70%
Scale AI2-1.80%
Ramp2-2.10%
Kraken8-3.00%
SingleStore1-5.60%
Discord2-7.80%
Waymo2-9.60%
FloQast1-9.80%
Meesho1-10.10%
goPuff1-12.60%
Rapyd1-13.50%
Zipline6-13.60%
Tekion1-16.20%
Bytedance7-17.30%
Attentive1-21.00%
Fanatics1-22.40%
Lightmatter2-22.90%
Epirus1-23.50%
KoBold Metals1-24.50%
Zocdoc2-24.80%
Arctic Wolf1-25.50%
Upgrade2-28.30%
Plaid1-29.40%
Epic Games2-30.80%
Liquid Death2-32.20%
Snyk2-32.50%
OpenAI4-34.90%
Automation Anywhere1-35.50%
Flexport1-35.50%
Ripple6-35.80%
Einride2-37.40%
EquipmentShare1-41.70%
Course Hero1-44.50%
Patreon1-46.80%
Ursa1-48.00%
Oura Health2-50.70%
Dataminr2-52.20%
Turo2-54.70%
ConsenSys6-71.00%
ThoughtSpot1-72.70%
Impossible Foods1-85.10%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In November, 28% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 41% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Click Therapeutics, GOAT, Anduril and Skydio had the highest positive variance in reported marks versus ZX Index Values. Impossible Foods, ThoughtSpot, ConsenSys and Turo had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Verge Genomics1.51$2.95$10.16$0.19
Evolve Vacation.88$5.62$18.08$3.66
CelLink.79$0.77$3.56$0.64
Carbon 3D.55$2.18$5.20$1.68
Automation Anywhere.54$6.25$10.86$3.75

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, Verge Genomics ($0.19 - $10.16) saw the highest share price variance across funds followed by Evolve Vacation ($3.66 - $18.08) and CelLink ($0.64 - $3.56).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Noodle, Asimov
7
Claris Bio
5
Lyra Health
5
Blink Health
4
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
TreelineBio
11
Saluda Medical
9
Redwood Materials
8
Reflexion Medical
7

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Noodle and Asimov saw their first positive reversals in seven quarters while Claris Bio and Lyra Health saw their first positive reversals in five quarters. Treeline Bio saw its first negative reversal in eleven quarters while Saluda Medical saw its first negative reversal in nine quarters.

Disclaimer

This report is based on data reported by 300+ funds and $70+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report November not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right